CHEMUNG FINANCIAL CORP
10-Q, 1995-08-08
STATE COMMERCIAL BANKS
Previous: PS PARTNERS V LTD, 10-Q, 1995-08-08
Next: FIDELITY LEASING INCOME FUND II, 10-Q, 1995-08-08



                                        
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON D.C. 20549
                                        
                                   FORM 10-Q





[X]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
        EXCHANGE ACT OF 1934

        For Quarterly period ended June 30, 1995  

[ ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
        EXCHANGE ACT OF 1934


        Commission File No. 0-13888


                         CHEMUNG FINANCIAL CORPORATION
             (Exact name of registrant as specified in its charter)



            New York                       16-1237038    
   (State or other jurisdiction of       I.R.S. Employer       
   incorporation or organization)        Identification No.


     One Chemung Canal Plaza, Elmira, NY         14902  
     (Address of principal executive offices)    (Zip Code)


                                 (607) 737-3711
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                              YES  XX       NO   

Indicate the number of shares outstanding of each of the issuer's
classes of common stock as of March 31, 1995:

           Common Stock, $5 par value -- outstanding 2,087,481 shares










                  CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARY
                                        
                                     INDEX


                                                        PAGE

PART I. FINANCIAL INFORMATION

Item 1: Financial Statements


   Condensed Consolidated Statements of Condition         1

   Condensed Consolidated Statements of Income            2

   Condensed Consolidated Statements of Cash Flow         3

   Notes to Condensed Consolidated Financial Statmts.     4


Item 2: Management's Discussion and Analysis of 
        Financial Condition and Results of Operations     6


PART II.     OTHER INFORMATION
                                 
Item 6: Exhibits and Reports on Form 8-K                  7


   All other items required by Part II are either
inapplicable or would require an answer which is negative.


SIGNATURES                                                9

PART I. FINANCIAL INFORMATION

Item 1: Financial Statements

<TABLE>
                        CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARY                   

                       CONDENSED CONSOLIDATED STATEMENTS OF CONDITION
<CAPTION>                                                                             
                                                            June 30        Dec 31    
                                                              1995          1994           
ASSETS                                                      Unaudited       Audited   
<S>                                                    <C>          <C>         
Cash and due from Banks                                $ 25,131,811 $ 24,380,592
Federal Funds Sold                                       10,200,000    8,000,000
Investment Securities Held to Maturity                   16,009,594   15,168,682
    (aggregate market value 1995 - $16,064,908                                    
                            1994 - $15,012,570                                    
                                                                                      
Investment Securities Available for Sale                157,711,472  189,123,633
  Allowance Valuation - Securities Available for Sale     4,892,983     (295,349)
                                                                                      
Total Investment Securities AFS - Adj. to Market        162,604,455  188,828,284
                                                                                      
Loans                                                   252,905,103  236,497,448
  Less: Allowance for Loan Losses                         3,883,290    3,599,968
                                                                                      
Loans, Net                                              249,021,813  232,897,480
                                                                                      
Bank Premises and Equipment, Net                          9,417,968    8,527,302
Goodwill and deposits base Intangible,                                           
  net of accumulated amortization                         8,283,888    8,577,540
Other Assets                                              7,192,548    7,952,438
                                                                                      
Total Assets                                           $487,862,077 $494,332,318

                                                                                      
LIABILITIES                                                                      
                                                                                      
Deposits:  Non-interest Bearing                        $ 75,834,946 $ 81,135,334
           Interest Bearing                             344,697,391  351,135,386

Total Deposits                                          420,532,337  432,270,720
Securities sold under Agreement to Repurchase             9,418,725   10,203,785
Other Liabilities                                         7,577,956    6,119,067
                                                                                      
Total Liabilities                                       437,529,018  448,593,572

                                                                                      
SHAREHOLDERS' EQUITY                                                             
                                                                                      
Common Stock (Authorized 3,000,000; Issued 2,150,067)    10,750,335   10,750,335
Surplus                                                  10,068,563   10,068,563
Retained Earnings                                        28,029,783   26,374,590
Cost of Treasury Shares (Deduction) 62,586-1995                                  
                                    56,586-1994          (1,432,549)  (1,279,549)
                                                                                      
Unrealized G/L Security Valuation-Avail. for Sale         2,916,927     (175,193)
Total Shareholders' Equity                               50,333,059   45,738,746

Total Liabilities & Shareholders' Equity               $487,862,077 $494,332,318
                                                                                
     See Accompanying Notes to Condensed Consolidated Financial Statements            

</TABLE>

<TABLE>
                     CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARY                       

                      CONDENSED CONSOLIDATED STATEMENTS OF INCOME                          
                                                                                         
                                  Unaudited                                              
<CAPTION>                                                                                
                                         6 Months Ended            3 Months Ended                          
                                             June 30                   June 30
INTEREST INCOME                         1995         1994         1995         1994                       
<S>                                <C>          <C>           <C>          <C>
Interest and Fees on Loans         $11,502,463  $ 9,685,249   $5,919,074   $4,806,550
Interest and Dividends on                                                                                  
  Investment Securities              5,975,512    3,819,475    2,870,782    2,066,036
Interest on Federal Funds Sold         237,882      183,981      122,224       92,204
Income Interest Bearing Deposits        90,184       67,662       50,972       61,813
                                                                                                           
  Total Interest Income             17,806,041   13,756,367    8,963,052    7,026,603
                                                                                                       
INTEREST EXPENSE                                                                         
                                                                                                        
Deposits                           $ 6,668,929  $ 4,376,142   $3,360,765   $2,262,410
Securities Sold Under Agreements                                                          
  to Repurchase and Funds Borrowed     418,761      143,783      182,889       72,657
                                                                                          
  Total Interest Expense           $ 7,087,690   $ 4,519,925  $3,543,654   $2,335,067
                                                                                          
  Net Interest Income              $10,718,351   $ 9,236,442  $5,419,398   $4,691,536
                                                                                        
Provision for Loan Losses              400,000       250,000     200,000      125,000
                                                                                          
  Net Interest Income after 
    Provision for Loan Losses      $10,318,351   $ 8,986,442  $5,219,398   $4,566,536
Realized Gains-Security Trans.         325,154       139,985     279,875      139,978
Other Operating Income               2,923,057     2,673,066   1,453,841    1,327,522
                                   $13,566,562   $11,799,493  $6,953,114   $6,034,036
                                                                                        
Other Operating Expenses           $ 9,580,223   $ 8,244,775  $4,806,651   $4,201,615
                                                                                        
Income before Taxes                  3,986,339     3,554,718   2,146,463    1,832,421
Income Taxes                         1,327,716     1,207,403     741,961      631,903
                                                                                                           
                                                                    
Net Income                         $ 2,658,623   $ 2,347,315  $1,404,502   $1,200,518
                                                                                                           
                                                                    
Net Income per Share               $1.27         $1.24        $.67         $.63





See Accompanying Notes to Condensed Consolidated Financial Statements                    
</TABLE>

<TABLE>
                             CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARY              

                            CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
                                                                                       
<CAPTION>                                                                                       
                                                                                       
                                                                  Six Months Ended   
                                                                       June 30        
                                                                1995           1994    
     OPERATING ACTIVITIES                                                              
     <S>                                                    <C>           <C>         
     Net Income                                             $  2,658,623  $   2,347,315
     Adjustments to Reconcile Net Income to Net Cash                                   
     Provided by Operating Activities:                                                 
        Amortization of Deposit Base Intangible                  293,652              0
        Provision for Loan Losses                                400,000        250,000
        Provision for Depreciation and Amortization              553,777        462,818
        Amortization for Investment Securities, Net             (257,591)      (497,564)
        (Gain) Loss on Investment Security Sales, Net           (325,154)      (139,985)
        (Increase) Decrease in Accrued Interest Receivable                             
            and Other Assets                                     759,890     (6,458,479)
        Increase (Decrease) in Accrued Interest Payable,                               
            Taxes and Other Liabilities                        1,413,921      1,003,110
                                                                                       
     Net Cash Provided by Operating Activities                 5,497,118     (3,032,785)
                                                                                       
                                                                                       
                                                                                       
     INVESTING ACTIVITIES                                                              
                                                                                       
     Proceeds from Maturities of Securities - AFS             41,151,126     42,658,176
     Proceeds from Maturities of Securities -HTM               4,471,292      2,375,975
     Proceeds from Sales of Securities - AFS                   5,445,178     10,239,418
     Purchases of Securities - AFS                           (16,687,338)  (119,839,740)
     Purchases of Securities - HTM                            (5,322,476)    (5,398,602)
     Purchases of Bank Premises and Equipment, Net            (1,444,443)      (468,130)
     Loan Originations, Net of Repayments                                              
       and Other Reductions                                  (17,381,792)      (318,096)
     Proceeds from Sale of Student Loans                         857,459      1,010,365
                                                                                       
     Net Cash Used by Investing Activities                    11,089,006    (69,740,634)
                                                                                       
                                                                                       
                                                                                       
     FINANCING ACTIVITIES                                                              
                                                                                     
     Deposits of Acquired Branches                                     0     45,628,085
     Net Increase (Decrease) in Demand Deposits, NOW,                                  
       Savings and Insured Money Market Accounts             (17,692,587)     4,758,457
     Net Increase (Decrease) in Certificates of Deposit                                
       and Individual Retirement Accounts                      5,954,204     (1,774,440)
     Net Increase (Decrease) in Short term Borrowings           (785,060)    (5,554,948)
     Sale of Treasury Shares                                           0        172,500
     Purchase of Treasury Shares                                (153,000)             0
     Cash Dividends Paid                                        (958,462)      (862,844)
                                                                                       
     Net Cash Provided by Financing Activities               (13,634,905)    42,366,810
                                                                                       
     Net Increase (Decrease) in Cash and Cash Equivalents      2,951,219    (30,406,609)
     Cash and Cash Equivalents at Beginning of Year           32,380,592     65,055,776
                                                                                       
     Cash and Cash Equivalents at End of Period              $35,331,811    $34,649,167
                                                                                       
     See Accompanying Notes to Condensed Consolidated Financial Statements             
</TABLE>


                  CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARY
                                        
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.     Chemung Financial Corporation, a one-bank holding company, commenced
       operations on June 1, 1985 for the purpose of acquiring all the 
       outstanding shares of the Chemung Canal Trust Company, Elmira, NY.  The 
       Trust Company's stock was acquired through the issuance of 431,498 shares
       of the Corporation's stock in a transaction accounted for as a pooling of
       interests.

2.     In the opinion of management, the consolidated financial statements 
       included herein contain all adjustments necessary to present fairly the 
       financial position as of June 30, 1995 and December 31, 1994, the results
       of operations for the six month period ending June 30, 1995 and 1994 and 
       the changes in cash flow position for the six-month period ending 
       June 30, 1995 and 1994.

3.     Net income per share for the periods presented have been computed by 
       dividing net income by 2,090,481 average shares outstanding on June 30, 
       1995 and 1,898,863 average shares outstanding on June 30, 1994.

4.     The Financial Accounting Standards Board issued Statement 114 Accounting 
       by Creditors for Impairment of a Loan as amended by Statement 118, 
       Accounting by Creditors for Impairment of a Loan - Income and Disclosure.
       These statements prescribe recognition criteria for loan impairment, 
       generally related to commercial type loans, and measurement methods for 
       certain impaired loans and all loans whose terms are modified in troubled
       debt restructuring subsequent to the adoption of these statements.  A 
       loan is considered impaired when it is probable that the borrower will be
       unable to repay the loan according to the original contractual terms of 
       the loan agreement.

       As of January 1, 1995, the Company has adopted the provisions of SFAS No.
       114 and SFAS No. 118 and has provided the required disclosures.  The 
       effect of adoption was not material to the consolidated financial 
       statements.  As of January 1, 1995, the company had no in substance 
       foreclosed assets to be reclassified into impaired loan status as 
       required by SFAS No. 114.  For all prior periods presented, there were no
       in substance foreclosures to be reclassified.

       As a result of the adoption of SFAS No. 114, the allowance for possible 
       loan losses related to impaired loans that are identified for evaluation 
       in accordance with SFAS No. 114 is based on the present value of expected
       cash flows discounted at the loan's initial effective interest rate, 
       except that as a practical expedient, impairment may be measured at the 
       loan's observable market price, or the fair value of the collateral for 
       certain loans where repayment of the loan is expected to be provided 
       solely by the underlying collateral (collateral dependent loans).  The 
       Company considers estimated costs to sell, on a discounted basis, when 
       determining the fair value of collateral in the measurement of impairment
       if those costs are expected to reduce the cash flows available to repay 
       or otherwise satisfy the loans.  Prior to the adoption of SFAS No. 114 
       and 118, the allowance for possible loan losses related to these loans 
       was based on estimated undiscounted cash flows or the fair value of the 
       collateral, less estimated costs to sell for collateral dependent loans.

       Other real estate owned included only formally foreclosed, and no 
       in-substance foreclosed real properties.  In accordance with SFAS 
       No. 114, a loan is classified as an in-substance foreclosure when the 
       Company has taken possession of the collateral regardless of whether 
       formal foreclosure proceedings have taken place.  Prior to the adoption 
       of SFAS No. 114 and SFAS No. 118, in-substance foreclosed properties 
       included those properties where the borrower had little or no remaining 
       equity in the property considering its fair value remaining equity; where
       repayment was only expected to come from the operation or sale of the 
       property; and where the borrower had effectively abandoned control of the
       property or it was doubtful that the borrower would be able to rebuild 
       equity in the property.

       Changes in the allowance for possible loan losses for the six months 
       ended June 30, 1995 is as follows:
       <TABLE>
       <S>                                               <C>
       Amount (000's)
       Balance at beginning of period                    3,600
       Provisions for possible loan losses                 400
       Loans charged off                                  (176)
       Recoveries on loans previously charged off           59
       Balance at end of period                          3,883
       </TABLE>

       At June 30, 1995, the recorded investment in loans that are considered to
       be impaired under SFAS No. 114 totaled $642,915.  Included in this amount
       is $491,450 of impaired loans for which the related allowance for credit 
       losses is $252,370.  In addition, included in the total impaired loans at
       June 30, 1995 is $151,465 of impaired loans that as a result of the 
       adequacy of collateral values, do not have an allowance for credit losses
       determined in accordance with SFAS No. 114.  The average recorded 
       investments in impaired loans during the three months ended June 30, 1995
       was approximately $694,391.

       Impaired loans are included in non-performing loans, generally 
       as non-accrual loans.  Commercial type loans past due greater than 90 
       days and still accruing are generally not considered to be impaired as 
       the Company expects to collect all amounts due, including interest 
       accrued at the contractual interest rate for the delinquent period.  The 
       Company had no restructured loans prior to the adoption of SFAS No. 114.

       In general, interest income on impaired loans is recorded on a cash basis
       when collection in full is reasonably expected.  If full collection is
       uncertain, cash receipts are applied first to principal, then to interest
       income.

       For the three months ended June 30, 1995 the Company recognized interest
       income on those impaired loans of $5,019 which included $3,222 of 
       interest income recognized using the cash basis method of income 
       recognition.


Item 2:   Management's Discussion and Analysis of Financial Condition and 
          Results of Operations


       Consolidated total assets at June 30, 1995 were $487.9 million, a decline
of $6.4 million (1.3%) from the beginning of the year.  This is within the 
expectations of management as the Corporation moved to assimilate the operations
of four branches acquired during 1994.  With the loan to deposit ratio at 54.7%
at the beginning of the year, there was little need to aggressively pursue
additional deposits through aggressive interest rate bidding.

       Loan business, in accordance with the Corporation's plan, has been strong
in the commercial and auto loan areas and the long-term decline in 1-4 family
mortgage loans has been reversed during the period.  Total loans at the end of
June 1995 were $252.9 million, up $7.6 million (3.1%) for the second quarter and
$16.4 million (6.9%) since the beginning of the year.

       Total deposits at June 30, 1995 were $421 million, down $30 million 
(6.7%) from the beginning of the quarter and $11.7 million (2.7%) from December 
31, 1994.  March 31 deposit balances represented somewhat of a distortion as 
local school districts received and deposited their NYS State Aid checks on that
date, increasing their balances by approximately $25 million.  Average total 
deposit balances during the quarter were about $416 million.  The loan to 
deposit ratio at June 30 was 60.1%.

       The Available for Sale segment of the securities portfolio at June 30, 
1995 was $157.7 million, compared to $174 million at March 31 and $189 million 
at the beginning of the year.  Interest rates continued to trend lower during 
the quarter, causing the Allowance valuation to increase to $4.9 million at 
June 30, compared to $2.5 million at March 31 and $-295 thousand at December 31,
1994.


       Consolidated net earnings for the second quarter of 1995 were $1.405 
million, up $204 thousand (17%) over the second quarter of 1994.  Net earnings 
per share for the quarter were $0.67 vs $0.63, an increase of $0.04 (6.4%) on 
197 thousand additional shares outstanding.  Net earnings per share for the six 
month period were $1.27 vs $1.24 (2.4%) on 191 additional shares outstanding.  
The additional shares were issued in connection with the December 31, 1994 
acquisition of the Owego National Bank in a tax exempt transaction which became 
effective on the first day of business of 1995.  Due to the sustained increase 
in loan demand, management decided to increase the loan loss provision to $200 
thousand during the first quarter and continued the allocation in the second 
quarter.  At 343% of non-performing loans and 1.53% of total loans, the reserve 
is viewed by management as adequate relative to risk.  Non-performing loans at 
June 30, 1995 constituted 0.43% of total loans. 


       The Owego acquisition was accounted for on a "purchase" accounting basis,
a treatment which resulted in a good will intangible amounting to $2.7 million 
at June 30, 1995.  This intangible is being amortized on a straightline basis 
over fifteen years.  The amortization of good will is an after-tax expense.

       The core deposit intangible in the amount of $5.5 million at June 30, 
1995, which accounts for the premium paid in connection with the acquisition of 
three branches from the Resolution Trust Corporation in June of last year, is 
being amortized over 15 years for both book and tax purposes. Our actual 
experience with the deposit accounts acquired in this transaction is under 
continuing review.

       On June 30, 1995, the Corporation's consolidated leverage ratio was 7.99%
versus 7.52% on March 31, and 7.51% at the beginning of the year.  The Tier I 
and Total Risk Adjusted Capital ratios were 13.39% and 14.89%, respectively.
       

PART II.  OTHER INFORMATION

Item 6.      Exhibits and Reports on Form 8-K

(a)    Applicable Exhibits
             
       (3.1) Certificate of Incorporation is filed as Exhibit 3.1 to
             Registrant's Registration Statement on Form S-14, Registration No.
             2-95743, and is incorporated herein by reference.


             Certificate of Amendment to the Certificate of Incorporation, filed
             with the Secretary of State of New York on April 1, 1988, is
             incorporated herein by reference to Exhibit A of the registrant's
             Form 10-K for the year ended December 31, 1988, File No. 0-13888.


       (3.2) Bylaws of the Registrant, as amended to March 8, 1995 are 
             incorporated herein by reference to Exhibit A of the registrant's
             Form 10-Q for the quarter ended March 31, 1995, File No. 0-13888. 
                        
       (27)  Financial Data Schedule (EDGAR version only)

(b)    Reports on Form 8-K

       During the quarter ended June 30, 1995, no reports on Form 8-K or 
       amendments to any previously-filed Form 8-K were filed by the registrant.






                                        
                                        
                                        
                                   SIGNATURES




Pursuant to the requirements of the Securities Exchange Act of 1934,  the
registrant has duly caused this report to be signed on its behalf by the
undersigned there to duly authorized.

                         CHEMUNG FINANCIAL CORPORATION



DATE: August 7, 1995                            /s/ John W. Bennett      
                                                John W. Bennett
                                                President & CEO



DATE: August 7, 1995                            /s/ Jan P. Updegraff
                                                Jan P. Updegraff
                                                Vice President &
                                                    Treasurer






















<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S UNAUDITED QUARTERLY FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE
30, 1995 AS PRESENTED IN ITS SECOND QUARTER FORM 10-Q AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                          24,911
<INT-BEARING-DEPOSITS>                             221
<FED-FUNDS-SOLD>                                10,200
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    157,711
<INVESTMENTS-CARRYING>                          16,010
<INVESTMENTS-MARKET>                            16,065
<LOANS>                                        252,905
<ALLOWANCE>                                      3,883
<TOTAL-ASSETS>                                 487,862
<DEPOSITS>                                     420,532
<SHORT-TERM>                                     9,419
<LIABILITIES-OTHER>                              7,578
<LONG-TERM>                                          0
<COMMON>                                        10,750
                                0
                                          0
<OTHER-SE>                                      39,583
<TOTAL-LIABILITIES-AND-EQUITY>                 487,862
<INTEREST-LOAN>                                 11,502
<INTEREST-INVEST>                                5,976
<INTEREST-OTHER>                                   328
<INTEREST-TOTAL>                                17,806
<INTEREST-DEPOSIT>                               6,669
<INTEREST-EXPENSE>                               7,088
<INTEREST-INCOME-NET>                           10,718
<LOAN-LOSSES>                                      400
<SECURITIES-GAINS>                                 325
<EXPENSE-OTHER>                                  9,580
<INCOME-PRETAX>                                  3,986
<INCOME-PRE-EXTRAORDINARY>                       2,659
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,659
<EPS-PRIMARY>                                     1.27
<EPS-DILUTED>                                     1.27
<YIELD-ACTUAL>                                    4.84
<LOANS-NON>                                        987
<LOANS-PAST>                                       525
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 3,600
<CHARGE-OFFS>                                      176
<RECOVERIES>                                        60
<ALLOWANCE-CLOSE>                                3,883
<ALLOWANCE-DOMESTIC>                               566
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                          3,317
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission